This document provides a 973-page report on diagnostic testing markets outside main hospital laboratories, such as emergency rooms, operating rooms, and intensive care units. It includes analysis of market dynamics, size, growth trends, technologies, and business opportunities. The report segments the market and provides test volume and sales forecasts for over 300 procedures. It also reviews leading point-of-care diagnostic instruments and emerging technologies. Strategic recommendations are provided for new product opportunities and alternative market expansion strategies.
Innovative Clinical Chemistry and Immunodiagnostic Technologies and Emerging ...ReportLinker.com
This unique 1,115-page report contains 450 tables, and provides sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for 100 chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, calibrators and controls. Available by country and section.This unique worldwide market intelligence and technology assessment report will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next ten years.The clinical chemistry and immunodiagnostics markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, begin to resemble commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Innovative Clinical Chemistry and Immunodiagnostic Technologies and Emerging ...ReportLinker.com
This unique 1,115-page report contains 450 tables, and provides sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for 100 chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, calibrators and controls. Available by country and section.This unique worldwide market intelligence and technology assessment report will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next ten years.The clinical chemistry and immunodiagnostics markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, begin to resemble commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Chiral Chromatography has evolved over the years and has become a method of choice for analysis, identification, and purification of a wide variety of compounds. The market has seen an extraordinary amount of technological advancements in the last few years, as companies have introduced new systems that perform chromatographic procedures inlesser amounts of time and provide more detailed results. The chiral chromatography column market size was $68 million in 2013 and is expected to reach $87.8 million by 2018, at a CAGR of 5.2%.
The Preparative and Process Chromatography | Find out - Market Size | Market ...Akash Jaiswal
The Preparative and Process Chromatography market size, in terms of value, is expected to reach $8,950 million by 2019 from $6,351.5 million in 2014, at a CAGR of 7.1%. The Process Chromatography market is segmented on the basis of products and services, end user, and geography.
This report provides comprehensive information on the therapeutic development for Uveal Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Uveal Melanoma and special features on late-stage and discontinued projects.
http://www.researchmoz.us/uveal-melanoma-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diarrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/diarrhea-pipeline-review-h1-2015-report.html
The U.S. medical plastics market is expected to reach almost 3.5 billion pounds by the end of 2010 and will grow at a compound annual growth rate (CAGR) of about 5%, consuming about 4.4 billion pounds by 2015.Commodity thermoplastics dominate the market with a little more than 55% of total volume. This sector is estimated at nearly 2 billion pounds in 2010 and should increase at a compound annual growth rate (CAGR) of 4.8% to reach 2.5 billion pounds in 2015.TPEs, engineering resins, and thermosets will show the most significant growth rates over the next 5 years although they only constitute about 20% of total volume. Of these, TPEs will experience the highest compound annual growth rate (CAGR) of 6.2%, from 68 million pounds in 2010 to 92 million pounds in 2015.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. However, this evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period.
BüroWARE®room - ERP für Hotels, Gästehäuser und Pensionensoftenginegmbh
BüroWARE room bietet Ihnen
- eine ganzheitliche Lösung für alle Bereiche Ihres Hauses von der Reservierung über das
Einchecken bis zum kompletten Finanzmanagement
- Zentrale Adressverwaltung
- Zimmer- und Objektverwaltung
- Reservierung / Buchung
- Abrechnung / Fakturierung
- Auswertungen und Statistiken
- BüroWARE Finanzbuchhaltung
- Lohn- und Gehaltsabrechnung
- Anbindung von Fremdsystemen
- Flexibilität als Strategie
Chiral Chromatography has evolved over the years and has become a method of choice for analysis, identification, and purification of a wide variety of compounds. The market has seen an extraordinary amount of technological advancements in the last few years, as companies have introduced new systems that perform chromatographic procedures inlesser amounts of time and provide more detailed results. The chiral chromatography column market size was $68 million in 2013 and is expected to reach $87.8 million by 2018, at a CAGR of 5.2%.
The Preparative and Process Chromatography | Find out - Market Size | Market ...Akash Jaiswal
The Preparative and Process Chromatography market size, in terms of value, is expected to reach $8,950 million by 2019 from $6,351.5 million in 2014, at a CAGR of 7.1%. The Process Chromatography market is segmented on the basis of products and services, end user, and geography.
This report provides comprehensive information on the therapeutic development for Uveal Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Uveal Melanoma and special features on late-stage and discontinued projects.
http://www.researchmoz.us/uveal-melanoma-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diarrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/diarrhea-pipeline-review-h1-2015-report.html
The U.S. medical plastics market is expected to reach almost 3.5 billion pounds by the end of 2010 and will grow at a compound annual growth rate (CAGR) of about 5%, consuming about 4.4 billion pounds by 2015.Commodity thermoplastics dominate the market with a little more than 55% of total volume. This sector is estimated at nearly 2 billion pounds in 2010 and should increase at a compound annual growth rate (CAGR) of 4.8% to reach 2.5 billion pounds in 2015.TPEs, engineering resins, and thermosets will show the most significant growth rates over the next 5 years although they only constitute about 20% of total volume. Of these, TPEs will experience the highest compound annual growth rate (CAGR) of 6.2%, from 68 million pounds in 2010 to 92 million pounds in 2015.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. However, this evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period.
BüroWARE®room - ERP für Hotels, Gästehäuser und Pensionensoftenginegmbh
BüroWARE room bietet Ihnen
- eine ganzheitliche Lösung für alle Bereiche Ihres Hauses von der Reservierung über das
Einchecken bis zum kompletten Finanzmanagement
- Zentrale Adressverwaltung
- Zimmer- und Objektverwaltung
- Reservierung / Buchung
- Abrechnung / Fakturierung
- Auswertungen und Statistiken
- BüroWARE Finanzbuchhaltung
- Lohn- und Gehaltsabrechnung
- Anbindung von Fremdsystemen
- Flexibilität als Strategie
020415 business storytelling by cynthia hartwigCynthia Hartwig
Anyone familiar with the Bible and Aesop’s fables already knows that stories are the oldest persuasive tool since the dawn of time. And now everybody from the The Wall Street Journal to LinkedIn is saying that storytelling will be the number one business skill needed in the next five years. That’s why you should run, don’t walk, to see the hands-on business storytelling workshop with Cynthia Hartwig, fiction writer and co-founder of Two Pens.
Over the course of her career in advertising and social media, Cynthia Hartwig has honed the act of telling stories into a fun and practical art. She’ll lead you in a series of practice-makes-perfect exercises that will help you to persuade, excite, sell and sway people to your point of view.
You’ll see how stories can be used in all kinds of business settings to communicate and connect with employees, customers, colleagues, partners, suppliers, and the media.
You’ll learn the mechanics of telling a story with a beginning that hooks you, to a middle that builds tension, to a satisfying end.
You’ll learn how to weave rich information (even numbers) with personal insights and emotional power and then experience the thrill of having an audience remember what you’ve said. Many writing exercises are included to help you tap into the mind’s unique hard-wiring that can create a story out of almost any experience.
The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan&...ReportLinker.com
During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The changes will be caused convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, will resemble commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."The Clinical Chemistry and Immunodiagnostics Markets" is a unique worldwide market intelligence and technology assessment study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities facing suppliers during the next ten years.Contains 1,115 pages and 450 tables
Discount discount.....research aarkstore enterprise point of care diagnostic...
Diagnostic Testing in Ancillary Hospital Locations: Innovative Technologies and Emerging Business Opportunities
1. Diagnostic Testing in Ancillary Hospital Locations: Innovative
Technologies and Emerging Business Opportunities
Report Details:
Published:December 2012
No. of Pages: 973
Price: Single User License – US$12500
This report provides comprehensive analysis of the diagnostic testing markets outside the main
hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics,
size, growth, regulatory requirements, technological trends, competitive landscape, and emerging
opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic
products suppliers develop more effective business, R&D and marketing strategies.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies,
intensifying competition among suppliers and physicians, and changing consumer demands are
shifting diagnostic testing from hospitals closer to the patient.
Market Segmentation Analysis
Review of the ER, OR and ICU market segments, including their dynamics, trends, structure, size,
growth and major suppliers.
Five-year test volume and sales forecasts for over 300 chemistry, immunodiagnostic,
microbiology, hematology and coagulation procedures by market segment:
•Emergency Rooms
•Operating/Recovery Suites
•ICUs/CCUs
and test category:
•Routine and Special Chemistry
•Microbiology/Infectious Diseases
•Hematology
•Flow Cytometry
•Coagulation
•Immunoproteins
•Drugs of Abuse
•TDM
•Endocrine Function
•Tumor Markers
2. Sales and Market Share Analysis
•Sales and market shares of major reagent and instrument suppliers.
•Current and Emerging Products
•Analysis of over 130 diagnostic procedures.
•Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers, both
currently marketed and those in development, including their operating characteristics, features
and selling prices.
•Technology Review
•Emerging technologies and their applications for POC testing.
•Comprehensive listings of companies developing or marketing POC diagnostic technologies and
products, by test.
Competitive Assessments
•Assessments of major suppliers and emerging market entrants, including their sales, product
portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
•Specific opportunities for new POC instruments and reagent systems with potentially significant
market appeal during the next ten years.
•Design criteria for POC testing products.
•Alternative business expansion strategies.
•Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and secondary sources of information, including
review of recent technical and business publications, manufacturer product literature, industry
analyst reports, and Venture Planning Group's proprietary data files.
Get your copy of this report @
http://www.reportsnreports.com/reports/209865-diagnostic-testing-in-ancillary-hospital-locations-innovative-
technologies-and-emerging-business-opportunities.html
Major points covered in Table of Contents of this report include
Table of Contents
Introduction
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
3. Worldwide Market and Technology Overview
Major Routine Chemistry Tests
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cholesterol
12. Cholinesterase
13. Creatinine
14. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
15. Ferratin
16. Follate/Folic Acid
17. Fructosamine
18. Gamma-Glutamyl Transpeptidase (GGT)
19. Glucose
20. High Density Lipoprotein (HDL)
21. Iron
22. Lactate Dehydrogenase (LDH)
23. Magnesium
24. Phosphorus
25. Protein
26. Triglycerides
27. Troponin
28. Uric Acid
29. Urinalysis
30. Vitamin B12
Infectious Disease Tests
1. AIDS
2. Adenovirus
3. Campylobacter
4. Candida
5. Chlamydia
4. 6. Clostridium Difficile
7. Cytomegalovirus
8. Enteroviruses
9. Epstein-Barr Virus
10. Gonorrhea
11. Helicobacter Pylori
12. Hepatitis
a. Hepatitis A
b. Hepatitis B
c. Hepatitis C
d. Hepatitis D
13. Herpes Simplex Virus
14. Human Herpes Virus-6 (HHV-6)
15. Influenza Viruses
16. Legionella
17. Lyme Disease
18. Measles (Rubeola)
19. Meningitis
20. Mononucleosis
21. Mumps
22. Mycoplasma
23. Papillomaviruses
24. Pneumonia
25. Respiratory Syncytial Virus (RSV)
26. Rheumatoid Arthritis
27. Rotavirus (Reovirus)
28. Rubella (German Measles)
29. Salmonellosis
30. Shigellosis
31. Staphylococcus Aureus
32. Streptococci
33. Syphilis
Tumor Markers
1. Alpha-Fetoprotein (AFP)
2. Carcinoembrionic Antigen (CEA)
3. Occult Blood
4. Prostatic Acid Phosphatase (PAP)
5. Prostate-Specific Antigen (PSA)
Major Routine and Special Hematology Tests
1. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
5. c. Red Blood Cell Count
d. Platelets
Endocrine Function Tests
1. Cortisol
2. Follicle-Stimulating Hormone (FSH)
3. Gastrin
4. Human Chorionic Gonadotropin (HCG)
5. LH
6. Prolactin
7. T3
8. T3 Uptake
9. Free T3
10. Thyroxine (T4)
11. Free T4
12. TBG
13. TSH
Therapeutic Drug Monitoring (TDM)
1. Overview
2. Carbamazepine
3. Digoxin
4. Gentamicin
5. Lidocaine
6. Lithium
7. Phenytoin/Dilantin
8. Procainamide
9. Quinidine
10. Theophylline
11. Valproic Acid
Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Factor VIII
8. Fibrin Degradation Products
9. Fibrinogen
10. Heparin
11. Proteins C and S
12. Prothrombin Time (PT)
13. Thrombin Time
7. Nihon Kohden
Polymedco
Sysmex
3. Coagulation Analyzers Manufactured by:
Behnk Elektronik
Bio/Data
Cardiovascular Diagnostics
Diagnostica Stago
Helena Laboratories
Instrumentation Laboratory
ITC Hemochron
Roche
Siemens
Sysmex
Teco Medical Instruments
Trinity Biotech
Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
8. Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
Worldwide Business Environment
U.S.A.
Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments
a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
9. a. Market Summary
b. Test Volume and Sales Forecasts
Major Suppliers’ Instrument Placements, Installed Base, Consumable Sales and Market
Shares
Major Product Development Opportunities
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
Abbott
ADI/America Diagnostica
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Biosite/Inverness
Biomerieux
Bio-Rad
Cephid
10. Chrono-Log
Corgenix
Dako
Decode
Diadexus
Diagnocure
Diagnostica Stago
Diamedix
Diasorin
Eiken Chemical
EKF Diagnostics
Fujirebio
Gen-Probe
Helena Laboratories
Hologic
Horiba
Instrumentation Laboratory
International Technidyne/Nexus DX
Kreatech
Kyowa Medex
Life Technologies
Lonza
Mackay Life Sciences
Matritech
Nihon Kohden
Polartechnics
Polymedco
Qiagen
SDIX
Sienco
Zycare/Alere
List of Tables
Major Companies Developing or Marketing Albumin Tests
Major Companies Developing or Marketing Alkaline Phosphatase Tests
Major Companies Developing or Marketing ALT/SGPT Tests
Major Companies Developing or Marketing Amylase Tests
Major Companies Developing or Marketing AST/SGOT Tests
Major Companies Developing or Marketing Bilirubin Tests
Major Companies Developing or Marketing Blood Gas Analyzers
Major Companies Developing or Marketing BUN Tests
Major Companies Developing or Marketing Calcium Tests
Major Companies Developing or Marketing Cholesterol Tests
11. Major Companies Developing or Marketing Creatinine Tests
Major Companies Developing or Marketing Electrolyte Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing GGT Tests
Major Companies Developing or Marketing Glucose Tests
Major Companies Developing or Marketing HDL Tests
Major Companies Developing or Marketing Iron Tests
Major Companies Developing or Marketing LDH Tests
Major Companies Developing or Marketing Magnesium Tests
Major Companies Developing or Marketing Phosphorus Tests
Major Companies Developing or Marketing Protein Tests
Major Companies Developing or Marketing Triglycerides Tests
Major Companies Developing or Marketing Uric Acid Tests
Major Companies Developing or Marketing Vitamin B-12/Folate Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing CEA Tests
12. Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing FSH Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing LH Tests
Major Companies Developing or Marketing Prolactin Tests
Major Companies Developing or Marketing T3 Tests
Major Companies Developing or Marketing T4 Tests
Major Companies Developing or Marketing TSH Tests
Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin/Dilantin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing Valproic Acid Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Altithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-Dimer Tests
Major Companies Developing or Marketing Factor Assays Tests
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing CRP Tests
Major Companies Developing or Marketing Drugs of Abuse Tests
Ancillary Hospital Locations Estimated Number
Ancillary Hospital Locations Annual Utilization
Hospital Emergency Departments Total Diagnostics Sales Forecast by Market Segment
Hospital Emergency Departments Reagent Sales Forecast by Market Segment
Hospital Emergency Departments Instrument Sales Forecast by Market Segment
Hospital Emergency Departments Routine and Special Chemistry Test Volume Forecast
Hospital Emergency Departments Profiles Panels and Individual Tests
Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
Hospital Emergency Departments Routine Hematology Test Volume Forecast
Hospital Emergency Departments Coagulation Test Volume Forecast
Hospital Emergency Departments Selected Infectious Disease Test Volume Forecast
13. Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by
Test
Hospital Emergency Departments Drugs of Abuse Reagent Market Forecast by Test
Hospital Emergency Departments Hematology Reagent Market Forecast
Hospital Emergency Departments Coagulation Reagent Market Forecast
Hospital Emergency Departments Selected Infectious Disease Reagent Market Forecast by Test
Hospital Operating and Recovery Suites Total Diagnostics Sales Forecast by Market Segment
Hospital Operating and Recovery Suites Reagent Sales Forecast by Market Segment
Hospital Operating and Recovery Suites Instrument Sales Forecast By Market Segment
Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Test Volume
Forecast
Hospital Operating and Recovery Suites Routine Hematology Test Volume Forecast
Hospital Operating and Recovery Suites Coagulation Test Volume Forecast
Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast
by Test
Hospital Operating and Recovery Suites Hematology Reagent Market Forecast
Hospital Operating and Recovery Suites Coagulation Reagent Market Forecast
Hospital ICUs/CCUs Total Diagnostics Sales Forecast by Market Segment
Hospital ICUs/CCUs Reagent Sales Forecast by Market Segment
ICUs/CCUs Instrument Sales Forecast by Market Segment
Hospital ICUs/CCUs Routine and Special Chemistry Test Volume Forecast
Hospital ICUs/CCUs Routine Hematology Test Volume Forecast
Hospital ICUs/CCUs Coagulation Test Volume Forecast
Hospital ICUs/CCUs Routine and Special Chemistry Reagent Market Forecast by Test
Hospital ICUs/CCUs Hematology Reagent Market Forecast
Hospital ICUs/CCUs Coagulation Reagent Market Forecast
Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Sales and Market Shares
Major Suppliers of Clinical Chemistry Reagents, Estimated Sales and Market Shares
Major Suppliers of Clinical Chemistry Analyzers, Estimated Sales and Market Shares
Major Suppliers of Immunodiagnostic Products, Estimated Sales and Market Shares
Major Suppliers of Immunoassay Reagents, Estimated Sales and Market Shares
Major Suppliers of Immunoassay Analyzers, Estimated Sales and Market Shares
AIDS Testing Market Estimated Market Shares of Major Suppliers
Chlamydia Testing Market Estimated Market Shares of Major Suppliers
CMV Testing Market Estimated Market Shares of Major Suppliers
Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
Hepatitis Testing Market Estimated Market Shares of Major Suppliers
Herpes Testing Market Estimated Market Shares of Major Suppliers
Influenza Testing Market Estimated Market Shares of Major Suppliers
Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
14. Rubella Testing Market Estimated Market Shares of Major Suppliers
Streptococci Testing Market Estimated Market Shares of Major Suppliers
Syphilis Testing Market Estimated Market Shares of Major Suppliers
AFP Testing Market by Major Supplier CA 15-3/27-29 Testing Market by Major Supplier
CA 19-9 Testing Market by Major Supplier CEA Testing Market by Major Supplier
PAP Testing Market by Major Supplier PSA Testing Market by Major Supplier
Hematology Analyzers Estimated Placements and Installed Base
Flow Cytometers Estimated Placements and Installed Base
Hematology Diagnostics Market Estimated Market Shares of Major Suppliers
Hematology Instrument Market Estimated Market Shares of Major Suppliers
Hematology Consumable Market Estimated Market Shares of Major Suppliers
Flow Cytometry Diagnostics Market Estimated Market Shares of Major Suppliers
Flow Cytometry Consumable Market Estimated Market Shares of Major Suppliers
Flow Cytometry Instrument Market Estimated Market Shares of Major Suppliers
Major Suppliers of Coagulation Diagnostic Products, Estimated Market Shares of Major Suppliers
Contact: sales@reportsandreports.com for more information.